Biogen (NAS: BIIB)

Biogen is a corporation based in Cambridge, Massachusetts. Established in 1978, the firm provides cures for neurodegenerative diseases, hemophilia, and autoimmune disorders. It also develops, markets, and manufactures therapies for people living with serious neurological, autoimmune, and rare diseases. The assets of the firm are managed by the board of directors, assisted by the finance committee.